Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.

Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E.

Circulation. 2007 May 29;115(21):2745-9. Epub 2007 May 14.

2.

Drug-eluting stents for infrainguinal occlusive disease: progress and challenges.

Tepe G.

Semin Vasc Surg. 2006 Jun;19(2):102-8. Review.

PMID:
16782516
3.

Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.

Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E.

N Engl J Med. 2006 May 4;354(18):1879-88.

4.

PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells.

Ryer EJ, Hom RP, Sakakibara K, Nakayama KI, Nakayama K, Faries PL, Liu B, Kent KC.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):780-6. Epub 2006 Feb 9.

5.

Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.

Kobayashi K, Yokote K, Fujimoto M, Yamashita K, Sakamoto A, Kitahara M, Kawamura H, Maezawa Y, Asaumi S, Tokuhisa T, Mori S, Saito Y.

Circ Res. 2005 Apr 29;96(8):904-12. Epub 2005 Mar 24.

6.

Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis.

Skowasch D, Jabs A, Andrié R, Dinkelbach S, Schiele TM, Wernert N, Lüderitz B, Bauriedel G.

J Vasc Res. 2004 Nov-Dec;41(6):525-34. Epub 2004 Oct 28.

PMID:
15528935
7.

Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway.

Hollenbeck ST, Sakakibara K, Faries PL, Workhu B, Liu B, Kent KC.

J Surg Res. 2004 Aug;120(2):288-94.

PMID:
15234225
8.

Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development.

Hao H, Gabbiani G, Bochaton-Piallat ML.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1510-20. Epub 2003 Aug 7. Review.

9.

Two major Smad pathways in TGF-beta superfamily signalling.

Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K.

Genes Cells. 2002 Dec;7(12):1191-204. Review.

10.

Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation.

Glover C, Ma X, Chen YX, Miller H, Veinot J, Labinaz M, O'Brien E.

Am Heart J. 2002 Oct;144(4):702-9.

PMID:
12360168
11.

The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferation.

Liu B, Itoh H, Louie O, Kubota K, Kent KC.

Surgery. 2002 Aug;132(2):317-25.

PMID:
12219029
12.

CCR2 deficiency decreases intimal hyperplasia after arterial injury.

Roque M, Kim WJ, Gazdoin M, Malik A, Reis ED, Fallon JT, Badimon JJ, Charo IF, Taubman MB.

Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):554-9.

14.

Replication in restenotic atherectomy tissue.

O'Brien ER, Urieli-Shoval S, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Benditt EP, Schwartz SM.

Atherosclerosis. 2000 Sep;152(1):117-26.

PMID:
10996346
15.

The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.

McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn TA, Deutsch E, Tarazona N, Shaknovitch A, Newman G, Patterson C, Bush HL Jr.

J Mol Cell Cardiol. 1999 Sep;31(9):1627-42.

PMID:
10471347
16.
17.

Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries.

Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A, Matsushima K, Sasayama S.

Circ Res. 1999 Feb 19;84(3):306-14.

18.

Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis.

Bauriedel G, Schluckebier S, Hutter R, Welsch U, Kandolf R, Lüderitz B, Prescott MF.

Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1132-9.

19.

The histologic characteristics of primary and restenotic carotid plaque.

Marek JM, Koehler C, Aguirre ML, Westerband A, Gentile AT, Mills JL, Hunter GC.

J Surg Res. 1998 Jan;74(1):27-33.

PMID:
9536969
20.

Histopathology of in-stent restenosis in patients with peripheral artery disease.

Kearney M, Pieczek A, Haley L, Losordo DW, Andres V, Schainfeld R, Rosenfield K, Isner JM.

Circulation. 1997 Apr 15;95(8):1998-2002.

Supplemental Content

Support Center